Emcure Pharmaceuticals gets CDSCO nod for MASH treatment in adults with liver fibrosis

Shares of Emcure Pharmaceuticals Ltd ended at ₹1,857.80, down by ₹73.95, or 4.15%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *